MLH1 Promoter Methylation, Paraffin
Ordering Recommendation
Distinguishes between Lynch syndrome and sporadic noncolorectal tumors with loss of MLH1.
Submit With Order
Real-Time Polymerase Chain Reaction/Fluorescence Resonance Energy Transfer
DNA isolation: Sun-Sat
Sun, Tue, Thu
10-12 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Tumor tissue.  
Specimen Preparation
Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue. Protect from excessive heat. Transport tissue block or 5 unstained 5-micron slides. (Min: 3 slides) Transport block and/or slide(s) in a tissue transport kit (ARUP supply #47808) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787.  
Storage/Transport Temperature
Room temperature. Also acceptable: Refrigerated. Ship in cooled container during summer months.  
Unacceptable Conditions
Frozen specimens. Specimens fixed/processed in alternative fixatives (alcohol, Prefer) or heavy metal fixatives (B-4 or B-5). Decalcified specimens.  
Include surgical pathology report. Tissue block will be returned after testing.  
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable  
Reference Interval
Interpretive Data
Refer to report.

This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.

See Compliance Statement B:
CPT Code(s)
88381; 81479
Component Test Code*Component Chart Name
0051749MLH1 Promoter Methylation
2002148Block ID
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Cross References
  • HNPCC screening
  • Lynch syndrome screening